Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ·Healthcare·Biotechnology
$11.75
-4.36%
Mkt Cap $217.75M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$27.00
Range $27.00 – $27.00
Implied Upside
+129.9%
Consensus $27.00 vs current $11.75